According to the International Agency for Research on Cancer (IARC), in 2022, there were approximately 20 million new cancer cases worldwide, with about 62.3% (approximately 12.5 million cases) occurring in individuals aged 60 and above. Similarly, out of the 9.7 million cancer-related deaths in 2022, 71.2% (approximately 6.9 million deaths) were among those aged 60 and above.

However, healthcare systems are not yet equipped to address the specific needs of this age group. Key challenges include the lack of age-appropriate research, limited treatment guidelines for older patients, and insufficient specialized training for healthcare professionals in geriatric oncology. These gaps in care are hindering the optimal treatment and management of older adults battling cancer.

SIOG’s Consortium’s Role

The SIOG Consortium is dedicated to bridging these gaps. By bringing together healthcare professionals, researchers, and organizations worldwide, SIOG is advancing clinical practice, developing specialized educational programs, and driving research that addresses the unique needs of older adults with cancer. Through collaboration, SIOG is working to set global standards for geriatric oncology, ensuring that older cancer patients receive the best possible care based on their age-specific health profiles.

Why This Matters to Your Organization

Joining the SIOG Consortium positions your company as a leader in the rapidly evolving field of geriatric oncology. As a member, your organization will have the opportunity to shape the future of cancer care for older adults through active involvement in developing clinical guidelines, supporting cutting-edge research, and engaging with a global network of professionals dedicated to advancing geriatric oncology. By partnering with SIOG, you’ll align your brand with a cause that is crucial to the future of healthcare, while enhancing your visibility in the global healthcare community.